NC
DGX icon

Nicholas Company’s Quest Diagnostics DGX Stock Holding History

Nicholas Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,331
Closed -$3.29M – 220
2025
Q2 		$3.29M Sell
18,331
-22,730
-55% -$3.95M 0.06% 209
2025
Q1 		$6.95M Sell
41,061
-5,319
-11% -$874K 0.12% 160
2024
Q4 		$7M Sell
46,380
-30
-0.1% -$4.67K 0.11% 164
2024
Q3 		$7.21M Hold
46,410
– – 0.12% 165
2024
Q2 		$6.35M Hold
46,410
– – 0.11% 173
2024
Q1 		$6.18M Buy
46,410
+3,575
+8% +$464K 0.1% 182
2023
Q4 		$5.91M Buy
42,835
+3,125
+8% +$411K 0.1% 182
2023
Q3 		$4.84M Sell
39,710
-140
-0.4% -$18.7K 0.1% 190
2023
Q2 		$5.6M Buy
39,850
+12,145
+44% +$1.67M 0.11% 184
2023
Q1 		$3.92M Buy
+27,705
New +$3.96M 0.08% 202
2020
Q4 		– Sell
-32,160
Closed -$3.68M – 231
2020
Q3 		$3.68M Sell
32,160
-21,325
-40% -$2.52M 0.08% 198
2020
Q2 		$6.09M Sell
53,485
-68,805
-56% -$7.3M 0.14% 161
2020
Q1 		$9.82M Sell
122,290
-125,710
-51% -$13M 0.28% 97
2019
Q4 		$26.5M Sell
248,000
-10,230
-4% -$1.07M 0.56% 61
2019
Q3 		$27.6M Hold
258,230
– – 0.62% 57
2019
Q2 		$26.3M Sell
258,230
-25
-0% -$2.4K 0.58% 58
2019
Q1 		$23.2M Buy
258,255
+15,345
+6% +$1.33M 0.55% 59
2018
Q4 		$20.2M Buy
242,910
+58,895
+32% +$5.52M 0.53% 60
2018
Q3 		$19.9M Buy
184,015
+163,665
+804% +$18M 0.43% 65
2018
Q2 		$2.24M Buy
+20,350
New +$2.12M 0.05% 209

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nicholas Company's DGX Position: Q3 2025 in Review

Nicholas Company sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 18,331 shares — an estimated $3.29M sold.

Nicholas Company first reported a position in DGX in Q2 2018 and held it in 20 quarters. The position peaked at $27.6M in Q3 2019. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Nicholas Company reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Nicholas Company sold 18,331 Quest Diagnostics shares in Q3 2025, an estimated $3.29M.
  • Nicholas Company first reported a position in Quest Diagnostics in Q2 2018 and held it in 20 quarters.
  • Nicholas Company's Quest Diagnostics position peaked at $27.6M in Q3 2019.
  • 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Nicholas Company's 13F filing for Q3 2025, filed 12 Nov 2025.